TAMPA, Fla., Oct. 6, 2016 -Nicopure Labs, LLC, the leading manufacturer of premium American-made e-liquids, has been presented with the "BMJ Most Committed to Quality" Golden Leaf Award at the 2016 Global Tobacco & Nicotine Forum (GTNF) in Brussels, Belgium. It is the first such award for the company. "We are [...]
In this webinar, recorded on August 11, 2016, Patricia Kovacevic answered questions live about the FDA Deeming Rule. @7:25 FDA Inspections @13:33 Mixing Liquids/Re-Labeling Products in Stores @17:15 Sampling @24:25 Online Sales, Advertising, and Apps @32:39 Update on Litigation @42:16 Consumers Handling Products Prior to Purchase @49:28 Repackaging Products About Nicopure Labs Nicopure Labs is a premium American [...]
TAMPA, Fla., July 12, 2016- Nicopure Labs, LLC, the leading manufacturer of American-made e-liquids, has filed a Motion for Summary Judgment in the U.S. District Court for the District of Columbia. This filing is the next phase in the company's challenge to the FDA's Deeming Rule, which began in May [...]
Patricia Kovacevic, General Counsel & Chief Compliance Officer at Nicopure Labs, discusses the UK's implementation of TPD2. DOWNLOAD THE DOCUMENT PATRICIA REVIEWS CONTENT OVERVIEW @0:58 EU legal framework @2:39 Update on EU entry gate for premarket notification @6:09 UK registration for cross-border sales to consumers @8:49 UK e-cigarette advertising @12:59 Where to go for information on UK TPD regulations ABOUT [...]
Patricia Kovacevic, General Counsel & Chief Compliance Officer at Nicopure Labs, provides insight into non-industry voices on tobacco harm reduction & vaping products. DOWNLOAD THE DOCUMENT PATRICIA REVIEWS CONTENT OVERVIEW @1:19 Introduction to Tobacco Harm Reduction @3:15 Governments and government-sponsored agencies or institutions @8:01 Public health non-governmental organizations (including tobacco control) @12:29 Individual tobacco control [...]
Nicopure Labs General Counsel and Chief Compliance Officer Patricia Kovacevic will be speaking at the Vapor Technology Association's upcoming conference on June 7th: VAPE & THE FDA: Understand It. Manage It. Patricia will also lead a panel of experts to discuss Substantial Equivalence under the FDA Deeming Rule at TMA’s June 9th conference .